Business
Medical Care Technologies Inc. (OTC PINK:MDCE) 2026 Annual Shareholder Update and Strategic Roadmap
Medical Care Technologies Inc. (OTC PINK:MDCE) 2026 Annual Shareholder Update and Strategic Roadmap.
About this update from Medical Care Technologies Inc.
[{"type":"text","content":"\r\n\r\n \r\n \r\n Medical Care Technologies Inc. (OTC PINK:MDCE) 2026 Annual Shareholder Update and Strategic Roadmap\r\n \r\n \r\n\r\n\r\nMedical Care Technologies Inc. (OTC PINK:MDCE) 2026 Annual Shareholder Update and Strategic Roadmap\r\n\r\n\r\n\r\n\r\n\r\nMESA, AZ / ACCESS Newswire / January 12, 2026 / Medical Care Technologies Inc. (OTC PINK:MDCE) (\"MDCE\" or the \"Company\"), a technology-focused company developing AI-driven consumer, wellness, and medical applications, today provided its 2026 annual shareholder update outlining its short-term, near-term, and long-term strategic goals as the Company advances its next phase of growth. These updates are also updated on our corporate website www.medicalcaretechnologies.com.\r\n Short-Term Goals (Coming Weeks / Months)\r\n Launch the Company's first completed consumer-based AI mobile application across 127 countries and 30 languages, demonstrating scalability, revenue potential, and global reach.\r\n Establish MDCE's first direct, non-subsidiary revenue stream through consumer AI applications.\r\n Announce the official name and branding of the first consumer app, accompanied by a coordinated launch campaign.\r\n Outline plans for multiple upcoming AI applications across health, wellness, and dietary categories to support near-term revenue generation.\r\n Continue development and testing of AI-based mobile applications addressing consumer and medical needs, including projects currently in prototype stages to be announced at a later date.\r\n Subsidiaries Infinite Auctions and Real Game Used to continue generating revenue through high-value collectible sales and AI-based authentication services, respectively.\r\n Near-Term Goals (2026)\r\n Develop and release one or more medical-grade beta applications.\r\n Conduct structured beta testing in collaboration with Arizona State University medical student groups.\r\n Advance select applications into clinical-grade efficacy testing with patient testing and a follow-up round supervised my medical professionals.\r\n Continue expanding the Company's and other AI platform capabilities to support both consumer and medical use cases.\r\n Long-Term Goals (2027 and Beyond)\r\n Pursue an uplisting to OTCQB, subject to meeting qualification standards, to enhance corporate credibility, transparency, and investor access.\r\n Complete the Comp...